5 Year Registry Study to Track Clinical Application of DecisionDx-UM Assay Results and Associated Patient Outcomes Uveal Melanoma is a rare cancer with approximately 3,000 cases diagnosed in the US every year. Nearly half of these experience spread of their cancer outside the eye. The DecisionDx-UM gen...

• Country None
• organs None
• Specialty None

Prospective Validation Study for the Proprietary Rectal and Anal Cancer Protein Expression Assays Patients with locally advanced rectal and esophageal carcinomas typically undergo neoadjuvant chemoradiation therapy prior to surgical resection. While response rates to this treatment dif...

• Country None
• organs None
• Specialty None

5-year Study to Track Clinical Application of DecisionDx-Melanoma Gene Expression Profile Assay Results The INTEGRATE Registry Study follows patients with cutaneous melanoma who have had the DecisionDx-Melanoma gene expression assay performed. Data will be collected through review of medical...

• Country None
• organs None
• Specialty None

Five Year Study to Track Use of DecisionDX-Melanoma Test in Patients With Cutaneous Melanoma and Associated Patient Outcomes The EXPAND Registry Study follows patients with cutaneous melanoma who have had the DecisionDx-Melanoma gene expression assay performed as part of their clinical care. Data will be collect...

• Country None
• organs None
• Specialty None